A Multi-Center, Open-Label Study To Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage II, III or IV CLL.
- Resource Type
- Abstract
- Source
- In
Blood 16 November 2006 108(11):4978-4978 - Subject
- Language
- ISSN
- 0006-4971